Article

Immunogenicity and safety of diphtheria-tetanus vaccine in pre-adolescent and adolescent South Koreans.

Department of Pediatrics, The Catholic University of Korea, Seoul, Republic of Korea.
Vaccine (impact factor: 3.77). 06/2009; 27(24):3209-12. DOI:10.1016/j.vaccine.2009.03.037 pp.3209-12
Source: PubMed

ABSTRACT This study was conducted to compare the immunogenicity and safety of diphtheria-tetanus (Td) vaccine between pre-adolescents aged 11-12 years and adolescents aged 13-18 years. A total of 277 subjects (132 pre-adolescents and 145 adolescents) participated. After vaccination, all subjects (100%) in both groups exhibited seroprotective antibody levels (> or =0.1I U/mL) against diphtheria or tetanus toxoids. Although local adverse events following vaccination were more frequently observed in the pre-adolescent group than in the adolescent group (p=0.006), these events resolved within 7 days. Our study shows Td vaccination at age 11-12 years to be immunogenic and tolerable.

0 0
 · 
0 Bookmarks
 · 
33 Views
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

132 pre-adolescents
 
145 adolescents
 
7 days
 
adolescent group
 
adolescents
 
diphtheria-tetanus
 
groups exhibited seroprotective antibody levels
 
immunogenic
 
immunogenicity
 
local adverse events
 
pre-adolescent group
 
pre-adolescents
 
Td
 
Td vaccination